FACT786.85

Fertilisers and Chemicals Travancore Ltd.

· Chemicals
AnnualQuarterly₹ CrorePeersRCFGSFCNFLPAUSHAKLTDTIRUMALCHMDEEPAKNTRCLEANCAMLINFINEMcap ₹50,915 Cr
View
In ₹ Crore except Per Share
12 Months Ending
Q4 FY23
31/03/2023
Q1 FY24
30/06/2023
Q2 FY24
30/09/2023
Q3 FY24
31/12/2023
Q4 FY24
31/03/2024
Q1 FY25
30/06/2024
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Revenue from Operations1,248.81,232.61,663.21,097.31,061.8599.61,448.6949.41,053.31,042.81,629.31,567.8
Other Income51.944.950.454.153.751.448.257.059.951.851.339.2
Total Income1,300.71,277.51,713.61,151.51,115.5650.91,496.81,006.41,113.21,094.61,680.61,607.1
Expenses
+ Cost of Materials Consumed920.1784.9715.8743.8749.0447.9582.3523.7705.7602.1831.61,015.4
+ Purchases of Stock-in-Trade1.0138.6144.395.3-14.41.2305.8186.9-16.4331.5434.1423.7
+ Changes in Inventories-320.3-179.6291.8-136.1-26.8-32.2241.0-53.1-19.1-175.712.6-147.7
+ Employee Benefit Expense81.176.282.471.454.071.676.173.553.674.181.669.2
+ Finance Costs61.362.661.261.661.562.061.461.860.361.761.961.8
+ Depreciation & Amortisation9.25.35.35.310.85.36.412.112.87.07.78.6
+ Other Expenses382.8265.6296.6279.8262.8167.6208.5186.9244.6186.7229.9250.2
Total Expenses1,135.11,153.61,597.41,121.11,096.9723.51,481.4991.71,041.61,087.51,659.41,681.1
EBITDA184.2146.9132.443.037.2-56.635.131.584.824.039.5-42.9
EBIT175.0141.7127.037.826.4-61.928.619.572.017.031.8-51.5
Profit
PBT before Exceptional Items165.6123.9116.230.318.7-72.615.414.771.67.121.2-74.1
+ Exceptional Items0.0-52.1-10.90.0-182.58.3-0.00.016.40.00.00.0
Pretax Income165.671.8105.230.3-163.9-64.315.414.788.07.121.2-74.1
+ Deferred Tax0.00.00.00.0-102.7-15.74.26.717.22.80.4-6.2
Tax Expense0.00.00.00.0-102.7-15.74.26.717.22.80.4-6.2
Net Income165.671.8105.230.3-61.2-48.711.28.070.74.320.9-67.9
+ Net Income — Continuing Ops165.671.8105.230.3-61.2-48.711.28.070.74.320.9-67.9
+ Other Comprehensive Income-8.80.025.20.0-4.70.028.00.06.50.04.50.0
Total Comprehensive Income156.871.8130.430.3-65.9-48.739.18.077.24.325.4-67.9
Per Share
Basic EPS2.561.111.630.47-0.950.750.170.121.090.070.32-1.05
Diluted EPS2.561.111.630.47-0.950.750.170.121.090.070.32-1.05
Other Comprehensive Income — detail
+ Other Comprehensive Income6.50.04.50.0
+ Items NOT to be Reclassified to P&L1.425.20.00.328.00.06.50.04.50.0
+ Items to be Reclassified to P&L-10.2-5.0
Per Share — as-filed variants
Basic EPS — Continuing Operations2.561.111.630.47-0.950.750.170.121.090.070.32-1.05
Diluted EPS — Continuing Operations2.561.111.630.47-0.950.750.170.121.090.070.32-1.05
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit648.0488.7511.3394.3353.9182.6319.7291.9383.0284.8351.0276.5
Gross Margin %51.8939.6530.7435.9333.3330.4522.0730.7536.3627.3121.5417.64
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)165.6123.9116.230.318.7-72.615.414.771.67.121.2-74.1
− Exceptional Items (reconciliation)0.0-52.1-10.90.0-182.58.3-0.00.016.40.00.00.0
Net Income Adj (tax-effected)165.6123.9116.230.311.8-54.911.28.057.64.320.9-67.9
EPS Adj2.561.921.800.470.180.850.170.120.890.070.32-1.05
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.00
Filed Debt Equity0.030.030.030.030.030.030.030.040.030.040.040.04
Filed Dscr0.000.000.000.000.000.000.000.000.000.000.000.00
Filed Iscr0.040.020.030.020.010.000.010.010.020.010.01-0.00
Paid Up Equity Capital647.1647.1647.1647.1647.1647.1647.1647.1647.1647.1647.1647.1
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q3 FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.